B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
about
Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppressionThe role of pembrolizumab in the treatment of advanced non-small cell lung cancerRole of the PD-1 pathway in the immune responseThe programmed death-1 immune-suppressive pathway: barrier to antitumor immunityMolecular mechanisms of T cell co-stimulation and co-inhibitionThe blockade of immune checkpoints in cancer immunotherapySafety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerImmunological battlefield in gastric cancer and role of immunotherapiesPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsImmune checkpoint blockade: a common denominator approach to cancer therapyThe role of the PD-1 pathway in autoimmunity and peripheral toleranceMechanisms of action of therapeutic antibodies for cancerBlockade of the B7-H1/PD-1 pathway for cancer immunotherapyBlockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like diseasePredictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patientsLymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cellsEmerging treatment options for the management of Hodgkin's lymphoma: clinical utility of nivolumab.Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cellsA potential new pathway for PD-L1 costimulation of the CD8-T cell response to Listeria monocytogenes infectionClinical Development of Immune Checkpoint Inhibitors.B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host diseaseThe novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivoBlockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.Cell surface signaling molecules in the control of immune responses: a tide model.Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation.Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells.Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System InflammationB7-H1 limits the entry of effector CD8(+) T cells to the memory pool by upregulating BimExpression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer.Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.PD-L1 mediated the differentiation of tumor-infiltrating CD19(+) B lymphocytes and T cells in Invasive breast cancerPD-L1 Expression Is Associated with Tumor FOXP3(+) Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient.Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance.
P2860
Q21089831-94C72B80-807B-47AA-AAFF-7173E7473300Q26744076-8BA8FCBE-692D-479B-82F3-E61798FB140FQ26828748-0229C9A0-C6BC-416C-A439-73B42AB7D129Q26829847-64B9A351-7DDA-4426-9603-40F6C43C4F8FQ26864888-0EDD46C7-39FB-44E4-9943-4F57BBFFDDA5Q27860852-8B62DEFC-E8D3-433D-92EE-ADD23B3454BCQ27860857-50747E23-9570-478B-B153-CAAE3C8FCBFEQ28071836-AA243685-93BD-4139-A1A4-965C03B9F8B2Q28075712-AE611F09-C7BA-41A3-A495-69BDF4601670Q28083981-996AA71A-AB5C-4DEC-BC99-FC9D2E0840EBQ28304161-FCB779FB-A879-4832-AC7B-870865D33D15Q28385366-A26BE114-8477-46E6-9976-11D26DBAA410Q28394869-251D219C-B51D-4DA7-BB7A-EAB7C482E4D1Q28590296-4847E6E1-6D26-4D9E-A300-067DF1F216C9Q29617771-5AFF2CEA-330D-499A-9B60-476270D2C678Q30415907-B3A447B6-1CAC-4431-906D-8F992779D54AQ33630143-49195021-843B-4B78-8A37-1268A0EC9157Q33704061-A268647F-32E6-46FF-A052-0FB4DA2C71A4Q33788235-0D044DC1-1F1F-4895-A547-D3AAC94ACC5DQ34080755-9BEAEB8F-5D03-4F3C-807B-3D92706AF8A8Q34586991-73EE7B21-A2BF-481B-9885-554B31252389Q34671498-46282CE4-809A-4B7E-B3B7-3AB69E4593E3Q34810629-E6CC8F61-CB73-44FA-9638-09FD1B1DCDB4Q35118927-1897376F-DC6A-4D12-ABDF-A9984F867C09Q35140721-E9D64437-D9AE-4753-A65D-6CD3F3A6179BQ35151883-FD66F4E2-2F04-4B10-9DD0-9F1A5A5312E0Q35223235-82CB2E08-1152-4DE8-8CC1-737FDE4993DFQ35681604-B6485488-0BF9-4D45-A35E-A09EA2C8098BQ35870655-0DC1DDF7-DC6C-4D41-AB98-CB8084C8D482Q36021225-DBBE6806-718D-4D33-AE25-A19F00EC8E65Q36024656-A745EA81-4C80-49BC-A012-CE81EC71BB93Q36039709-89315AE8-159C-421C-97F1-C815735DE6BDQ36106006-FB68A399-11DF-4F90-BF7F-C7D77F119D18Q36109112-13D75894-2F0B-48C1-9DEF-6278F910CFE6Q36388507-67D25EF6-0B03-46F5-B710-1E519FBA6E8DQ36517199-8E6C3E86-0417-41C9-99C6-1228E0A15F8AQ36522770-336DE11B-7382-43DD-8F2B-41971A736C5AQ36711049-7EEBC5F0-5F2D-45DA-A40D-48BB06FBBBDFQ36882550-43AD31AC-0A3F-4BCE-8494-0FE238F6CEBBQ36920276-A7F89530-673C-41E0-9A9C-C13CC9FE842A
P2860
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@ast
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@en
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@nl
type
label
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@ast
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@en
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@nl
prefLabel
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@ast
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@en
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@nl
P2093
P2860
P1433
P1476
B7-H1/CD80 interaction is requ ...... of peripheral T-cell tolerance
@en
P2093
Atsuo Kuramasu
Fumihiko Tsushima
Jang-June Park
Koji Tamada
Lieping Chen
Mathew M Augustine
Ryusuke Omiya
Scott E Strome
Yingjia Liu
P2860
P304
P356
10.1182/BLOOD-2010-01-265975
P407
P577
2010-05-14T00:00:00Z